SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-031559
Filing Date
2018-02-05
Accepted
2018-02-05 08:27:16
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d465186d424b5.htm 424B5 392872
2 GRAPHIC g465186g0202101600782.jpg GRAPHIC 3271
3 GRAPHIC g465186g0202101601000.jpg GRAPHIC 4044
4 GRAPHIC g465186g0202101601094.jpg GRAPHIC 3111
  Complete submission text file 0001193125-18-031559.txt   408792
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221382 | Film No.: 18572853
SIC: 2834 Pharmaceutical Preparations